Migraine Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increase in the Prevalence of Migraine
   3. Market Restraints
      1. Limited Efficacy of Current Treatments
      2. High Cost of Novel Therapies
   4. Market Opportunities
      1. Growth in Awareness
   5. Market Trends
      1. Personalized Medicine Approaches
      2. Expansion of Non-Pharmacological Therapies
5. MARKET SEGMENTATION
   1. By Product Type
      1. Acute Migraine Treatment
         1. Analgesic
         2. Ergotamine
         3. Triptans
      2. Preventive Migraine Treatment
         1. Beta Blockers
         2. Anti-serotonergic Drugs
         3. Antidepressants
         4. Anti-convulsant
         5. Calcium Channel Blockers
         6. Others
   2. By Route of Administration
      1. Oral
      2. Injection
      3. Others
   3. By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
   4. By End-Users
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Abbott
      2. Aegis Theraputics, LLC
      3. Aerial BioPharma LLC.
      4. Alder BioPharmaceuticals Inc.
      5. Amgen Inc.
      6. Aralez Pharmaceuticals Inc.
      7. Astellas Pharma India Private Limited
      8. AstraZeneca
      9. Bayer AGSitemap.
      10. CoLucid
      11. Dr. Reddy’s Laboratories Ltd.
      12. Ethypharm
      13. Eisai Co., Ltd.
      14. Eli Lilly and Company
      15. INTELGENX CORP.
      16. Global Information, Inc.
      17. Horizon Pharma plc.
      18. Johnson & Johnson Services, Inc
      19. Klaria
      20. KOWA Pharmaceuticals America, Inc.
      21. Luitpold Pharmaceuticals, Inc.
      22. LeProPharmaCompass OPC Private Limited
      23. Merck & Co.
      24. OptiNose US, Inc
      25. Pfizer Inc
      26. RedHill
      27. Suda Ltd
      28. TG Therapeutics, Inc.
      29. Teva Pharmaceutical Industries Ltd
      30. Valeant
      31. WINSTON PHARMACEUTICALS, Inc.
      32. Zogenix, Inc.
   2. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Migrainemarket?

The global market of Migraine is projected to reach USD 16.58 Bnby 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Migrainemarket?

The global Migraine market has an estimated annual growth rate of 15.6% .

Q.3. What are the recent trends of Migrainemarket?

Personalized medicine approaches and expansion of non-pharmacological therapies is oneof the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Migraine?

The major companies profiled in this report include Abbott, Aegis Theraputics, LLC, Aerial BioPharma LLC., Alder BioPharmaceuticals Inc., Amgen Inc., Aralez Pharmaceuticals Inc., Astellas Pharma India Private Limited, AstraZeneca, Bayer AGSitemap., CoLucid, Dr. Reddy’s Laboratories Ltd., Ethypharm, Eisai Co., Ltd., Eli Lilly and Company, INTELGENX CORP., Global Information, Inc., Horizon Pharma plc., Johnson & Johnson Services, Inc, Klaria, KOWA Pharmaceuticals America, Inc., Luitpold Pharmaceuticals, Inc., LeProPharmaCompass OPC Private Limited, Merck & Co., OptiNose US, Inc, Pfizer Inc, RedHill, Suda Ltd, TG Therapeutics, Inc., Teva Pharmaceutical Industries Ltd, Valeant, WINSTON PHARMACEUTICALS, Inc., Zogenix, Inc, among others.

Q.5. Which region is estimated to held highest CAGR inMigrainemarket?

North America is estimated to hold biggest share in the market for Migraine.